Gene · 406899
Papers3,773
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,773
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review). | Oncol Rep | 2026 | 41543151 | PubTator, text mining | PubMed |
| Advances in biomonitoring technologies for women's health. | Nat Commun | 2025 | 41006271 | PubTator, text mining | PubMed |
| Omics characteristics and epigenetic modifications of adipose-derived stem cells. | J Biol Chem | 2025 | 41005477 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| Advances in miRNA research: Unraveling the complexities of gene regulation. | Animal Model Exp Med | 2025 | 40947823 | PubTator, text mining | PubMed |
| Chemotherapy-induced alterations in miRNA expression and their prognostic implications in ovarian cancer. | Front Oncol | 2025 | 40919157 | PubTator, text mining | PubMed |
| Partners in Silencing: Decoding the Mammalian Argonaute Interactome. | Noncoding RNA | 2025 | 40863728 | PubTator, text mining | PubMed |
| Comparative Analysis of miRNA Expression 106a-5p and 375-3p and Proteins ERK1/2, p38, β-Catenin and E-Cadherin in Prostate Cancer and Benign Prostatic Hyperplasia. | J Cell Mol Med | 2025 | 40839490 | PubTator, text mining | PubMed |
| Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. | Eur J Med Res | 2025 | 40826140 | PubTator, text mining | PubMed |
| Reversing cardiac hypertrophy and heart failure using a cardiac targeting peptide linked to miRNA106a. | Clin Transl Med | 2025 | 40820483 | PubTator, text mining | PubMed |
| Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)/microRNA-302a-3p (miR-302a-3p)/ATPase Copper Transporting Beta (ATP7B) Axis. | MedComm (2020) | 2025 | 40761482 | PubTator, text mining | PubMed |
| Epigenetic modifications of gut microbiota and their potential role in atherosclerosis. | Front Pharmacol | 2025 | 40740992 | PubTator, text mining | PubMed |
| Prognostic value of miR-106a and miR-20a in AML patients with chemotherapy or allo-HSCT treatment. | Hematology | 2025 | 40699038 | PubTator, text mining | PubMed |
| Correlation and predictive modeling of serum exosomal miRNAs and serological biomarkers for lymph node metastasis in gastric cancer. | Am J Cancer Res | 2025 | 40667557 | PubTator, text mining | PubMed |
| Targeting microRNA-dependent control of X chromosome inactivation improves the Rett Syndrome phenotype. | Nat Commun | 2025 | 40615387 | PubTator, text mining | PubMed |
| The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer. | BMC Cancer | 2025 | 40597099 | PubTator, text mining | PubMed |
| microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disorders. | Neuroscience | 2025 | 40210196 | PubTator, text mining | PubMed |
| DNA‑Directed Assembly of Photonic Nanomaterials for Diagnostic and Therapeutic Applications. | Adv Mater | 2025 | 40103431 | PubTator, text mining | PubMed |
| Role of furin in the severity of COVID-19 infection via effects on miR-20b and miR-106a. | Mol Biol Rep | 2025 | 40095093 | PubTator, text mining | PubMed |
| MicroRNA-106a regulates the apoptosis and oxidative stress of porcine trabecular meshwork cells by targeting FAS. | Exp Eye Res | 2025 | 40032150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406899/papers?page=2